# Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)

> **NCT03549923** · PHASE4 · COMPLETED · sponsor: **Beijing Anzhen Hospital** · enrollment: 131 (actual)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DEVICE:** Simultaneous CRRT
- **DEVICE:** Conventional-indication CRRT
- **DRUG:** Esmolol
- **DRUG:** Standard care

## Key facts

- **NCT ID:** NCT03549923
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-18
- **Primary completion:** 2022-10-22
- **Final completion:** 2023-05-01
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2024-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03549923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03549923, "Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03549923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*